|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Gene Biotherapeutics Inc.
| | | Phone: | (858) 436-1000 | Fax: | (858) 436-1001 | Year Established: | 2003 | Ticker: | CRXM | Exchange: | OTCQB | Main Contact: | Christopher J. Reinhard, Chairman & CEO | | Other Contacts: | Lois A. Chandler, Ph.D., VP, Biologics Development Gabor M. Rubanyi, M.D., Ph.D., CSO
| | Company Description | Gene Biotherapeutics, formerly Taxus Cardium Pharmaceuticals, is monetizing its FDA-cleared, U.S.-patented, Excellagen, a highly-purified, aseptically-manufactured, fibrillar bovine collagen [2.6%] flowable dermal matrix for the treatment of diabetic neuropathic lower extremity ulcers, pressure and venous ulcers as well as other wound healing applications. | |
|
|
|
|
|